NCT05141877View on ClinicalTrials.gov

Influences of Propofol and Sevoflurane Anesthesia in Brain Tumor

PHASE4RecruitingINTERVENTIONAL
Enrollment

706

Participants

Timeline

Start Date

February 18, 2022

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2025

Conditions
Brain Tumor
Interventions
DRUG

Propofol

The propofol group was both induced and maintained at an effect-site concentration (Ce) of 2.0-4.0 mcg/mL by a target-controlled infusion (TCI) system.

DRUG

Sevoflurane

The sevoflurane group was maintained via sevoflurane vaporizer between 1% and 3% (target minimum alveolar concentration of 0.7-1.3).

Trial Locations (1)

Unknown

RECRUITING

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

All Listed Sponsors
collaborator

Tri-Service General Hospital

OTHER

lead

Kaohsiung Medical University Chung-Ho Memorial Hospital

OTHER